Literature DB >> 17035325

Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization.

Wu Ou1, Jonathan Silver.   

Abstract

Envelope glycoproteins (Envs) of retroviruses form trimers that mediate fusion between viral and cellular membranes and are the targets for neutralizing antibodies. Understanding in detail how Env trimers mediate membrane fusion, and how antibodies interfere with this process, is a fundamental problem in biology with practical implications for the development of antiviral drugs and vaccines. We investigated the stoichiometry of Env-mediated fusion and its inhibition by antibody by inserting an epitope from human immunodeficiency virus for a neutralizing antibody (2F5) into the surface (SU) or transmembrane (TM) protein of murine leukemia virus Env, along with point mutations that abrogate SU and TM function but complement one another. We transfected various combinations of these Env genes and investigated Env-mediated cell fusion and its inhibition by 2F5 antibody. Our results showed that heterotrimers with one functional SU molecule were fusion competent in complementation experiments and that one antibody molecule was sufficient to inactivate the fusion function of a trimer when its epitope was in functional SU or TM. 2F5 antibody could also neutralize trimers with the 2F5 epitope in nonfunctional SU or TM, but less efficiently.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035325      PMCID: PMC1676290          DOI: 10.1128/JVI.01318-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Structural basis for membrane fusion by enveloped viruses.

Authors:  W Weissenhorn; A Dessen; L J Calder; S C Harrison; J J Skehel; D C Wiley
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

2.  Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.

Authors:  W Weissenhorn; A Carfí; K H Lee; J J Skehel; D C Wiley
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

3.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin.

Authors:  D Fass; P S Kim
Journal:  Curr Biol       Date:  1995-12-01       Impact factor: 10.834

5.  Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5.

Authors:  R Kunert; F Rüker; H Katinger
Journal:  AIDS Res Hum Retroviruses       Date:  1998-09-01       Impact factor: 2.205

6.  Functional interactions between monomers of the retroviral envelope protein complex.

Authors:  Y Zhao; S Lee; W F Anderson
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.

Authors:  A Rein; C Yang; J A Haynes; J Mirro; R W Compans
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Functional domains in the retroviral transmembrane protein.

Authors:  Y Zhao; L Zhu; C A Benedict; D Chen; W F Anderson; P M Cannon
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Characterization of the proline-rich region of murine leukemia virus envelope protein.

Authors:  B Weimin Wu; P M Cannon; E M Gordon; F L Hall; W F Anderson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system.

Authors:  S C Kayman; H Park; M Saxon; A Pinter
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more
  1 in total

1.  Estimating the stoichiometry of human immunodeficiency virus entry.

Authors:  Carsten Magnus; Peter Rusert; Sebastian Bonhoeffer; Alexandra Trkola; Roland R Regoes
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.